ChromaDex Initiates Second Human Clinical Study for its Caffeine Ingredient, PURENERGY
date:May 15, 2014
successful human study. We have already had tremendous interest in PURENERGY and anticipate seeing numerous retail products launched in 2014 and beyond that incorporate PURENERGY as a compelling alternative ingredient to caffeine alone.

Results from the first study conducted in 2013 showed that PURENERGY delivers 30 percent more caffeine to the bloodstream and also extends the half-life of caffeine by 25 percent as compared to caffeine alone. The study results suggest:

- Formulators of energ
4/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/12 18:50